移植和非移植的HCC患者在一个机构
Brian I Carr1, Harika Bag2, Volkan Ince1,3
1Liver Transplant Institute, Inonu University School of Medicine, Malatya, Turkiye.
Hepatology forum
|March 15, 2024
概括
与非手术患者相比,肝细胞癌 (HCC) 的肝移植接受者表现出更好的生存率和更小的瘤. 在移植和非移植组中确定了预后因素.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 移植手术 移植手术
背景情况:
- 肝细胞癌 (HCC) 管理在医院部门之间分散.
- 建立了一个多学科的肝瘤委员会和机构数据库,以全面评估HCC患者.
研究的目的:
- 评估HCC患者的原因,瘤特征,治疗方法和生存率.
- 为了确定不同治疗组的预后参数.
主要方法:
- 从1322名HCC患者收集前性数据.
- 分析包括肝炎状态,瘤特征 (直径,数量,门静脉血栓症) 和血清标志物 (AFP,GGT,白蛋白).
主要成果:
- 肝移植患者 (n=444) 的存活时间明显更长,瘤较小 (MTD),肝硬化率高于非手术患者.
- 阿尔法-胎蛋白 (AFP) 和最大瘤直径 (MTD) 是移植患者的预后,特别是那些患有门静脉血栓症 (PVT) 患者.
- 在没有手术的组中,白蛋白是唯一被确定的预后因素.
结论:
- 肝移植改善了HCC患者的生存率和瘤特征.
- 特定的预后因素 (AFP,MTD,GGT) 对于量身定制治疗和预测不同HCC患者子组的结果至关重要.
相关概念视频
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...